In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arrow Therapeutics gets £21mm in Series B round

Executive Summary

Arrow Therapeutics Ltd. (anti-infectives) raised £21mm ($35mm) in its Series B round led by Atlas Venture. Additional new investors NIF Ventures, ITX, and Scottish Widows Investment Partnership participated along with return investors GIMV, Alta Partners, 3i, TVM, Unibio, and Northern Venture Managers.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies